Breaking News

Metrics Appoints Pharma Development Director

February 5, 2013

Cobb to manage early-phase OSD development

Joseph E. Cobb Jr., CPIP, has been appointed director of pharmaceutical development at Metrics, Inc. Mr. Cobb will manage all aspects of projects that involve early-phase solid oral dosage development. He also will oversee the company’s potent and cytotoxic drug development services, which include a dedicated and segregated potent facility.
 
Mr. Cobb has more than 20 years of industry experience, and holds the Certified Pharmaceutical Industry Professional credential from ISPE. He joined the company in 2002.
 
“Joe is a smart and capable leader who has been instrumental in guiding the success and growth of Metrics’ formulation development capabilities,” said Phil Hodges, president of Metrics. “With these new responsibilities, Joe will bring to his role the same thoughtfulness and resourcefulness.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important